Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    An Enquiry

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Tasocitinib Citrate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 11,709Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Biocon Pharma Gets FDA Nod For Arthritis Drug Tofacitinib ER
    Biocon Pharma Gets FDA Nod For Arthritis Drug Tofacitinib ER

    23 Nov 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/drug-approval/biocon-pharma-gets-fda-nod-for-arthritis-drug-tofacitinib-er-18314

    INDPHARMAPOST
    23 Nov 2025
    Share Share
    Biocon’s Generics Tofacitinib Receives Tentative Approval in US
    Biocon’s Generics Tofacitinib Receives Tentative Approval in US

    17 Nov 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219442

    FDA
    17 Nov 2025
    Share Share
    Sun Pharma’s Generics Xeljanz Receives Tentative Approval in US
    Sun Pharma’s Generics Xeljanz Receives Tentative Approval in US

    08 Oct 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218407

    FDA
    08 Oct 2025
    Share Share
    DeepCure Presents Ex Vivo Data For DC-9476 At ACR Convergence
    DeepCure Presents Ex Vivo Data For DC-9476 At ACR Convergence

    24 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241024256878/en

    BUSINESSWIRE
    24 Oct 2024
    Share Share
    Biora Therapeutics Presents Phase 1 Data For BT-600 At KOL Event
    Biora Therapeutics Presents Phase 1 Data For BT-600 At KOL Event

    18 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/18/2915229/0/en/Biora-Therapeutics-Announces-Supplemental-Data-from-Phase-1-Clinical-Trial-of-BT-600-as-Presented-at-KOL-Event.html

    GLOBENEWSWIRE
    18 Jul 2024
    Share Share
    Biora To Host KOL Event On NaviCap Platform And BT-600 Trial Results
    Biora To Host KOL Event On NaviCap Platform And BT-600 Trial Results

    08 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/08/2909602/0/en/Biora-Therapeutics-to-Host-Virtual-KOL-Event-on-NaviCap-Targeted-Oral-Delivery-Platform-and-Results-from-Phase-1-Clinical-Trial-of-BT-600-on-July-17-2024.html

    GLOBENEWSWIRE
    08 Jul 2024
    Share Share